Costs of Treatment of Chronic Obstructive Pulmonary Disease
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/5584_2015_199
Reference24 articles.
1. Ayres JG, Price MJ, Efthimiou J (2003) Cost-effectiveness of fluticasone propionate in the treatment of chronic obstructive pulmonary disease: a double blind randomized, placebo controlled trial. Respir Med 97:212–220
2. Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ (2009) Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 374:685–694
3. Caramori G, Adcock IM, Papi A (2009) Clinical definition of COPD exacerbations and classification of their severity. South Med J 102:277–282
4. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM (2008) Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 178:332–338
5. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring EJ, She D (2006) Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 1:63–70
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prescribing Patterns for Long-Acting Inhaled Bronchodilators Among Rural Adults With Chronic Obstructive Pulmonary Disease;Journal of Clinical Medicine Research;2022-09
2. Real-World Status of Medical Care and Treatment of Chronic Obstructive Pulmonary Disease by Respiratory Specialists in Japan;Advances in Therapy;2022-06-29
3. Towards precision in defining COPD exacerbations;Breathe;2021-09
4. The effect of teach-back training intervention of breathing exercise on the level of dyspnea, six-minutes walking test and FEV1/FVC ratio in patients with chronic obstructive pulmonary disease; a randomized controlled trial;Expert Review of Respiratory Medicine;2020-09-29
5. Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression;The International Journal of Tuberculosis and Lung Disease;2020-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3